RLSC.CN - RISE Life Science Corp.

Canadian Sec - Canadian Sec Delayed Price. Currency in CAD
0.245
-0.010 (-3.92%)
At close: 3:19PM EDT
Stock chart is not supported by your current browser
Previous Close0.255
Open0.000
Bid0.210 x 0
Ask0.225 x 0
Day's Range0.000 - 0.000
52 Week Range
Volume0
Avg. Volume45,715
Market Cap14.49M
Beta3.04
PE Ratio (TTM)N/A
EPS (TTM)-0.111
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • Newsfile14 days ago

    RISE Welcomes Ryan Rocca as New Board Member

    Toronto, Ontario--(Newsfile Corp. - August 3, 2018) - RISE Life Science Corp. (the "Company and/or "RISE") (CSE:RLSC) welcomes Ryan Rocca to its board of directors. Rocca is also named the General Manager of RISE Life Science Corp. USA and has also served as the President and Chief Executive Officer of the Cultivate Kind and Modern Marketing sister agencies, as well as Managing Partner of Life Bloom Organics.Rocca has a passion for bringing emerging brands ...

  • GlobeNewswire17 days ago

    RISE Expands Product Portfolio & Strengthens Organization with Acquisition -- CFN Media

    CFN Media Group (“CFN Media”), the leading agency and financial media network dedicated to the North American cannabis industry, announces publication of an article covering RISE Life Science Corp.'s (CSE:RLSC) recent acquisitions of two California-based companies to expand its product portfolio, intellectual property, and distribution channels. The U.S. cannabis industry is expected to reach more than $75 billion in size by 2030, according to Cowen & Co., driven by the legalization of medical and adult-use cannabis across a growing number of states. Not surprisingly, these rapid growth rates have spurred a lot of strategic acquisitions as cannabis brands look to establish dominance.

  • GlobeNewswirelast month

    Exclusive CFN Media Interview: RISE Life Science Study on Cannabis and Sexual Health (Part 2)

    CFN Media Group (“CFN Media”), the leading agency and financial media network dedicated to the North American cannabis industry, announces publication of an exclusive interview with Dr. Regina Nelson, who is leading a long-term study of sexual health and wellness and how it relates to cannabis for RISE Life Science Corp. (RLSC.CN) (RLSC.CN) (RLSC.CN). Dr. Nelson is working with RISE Life Science to implement a broad and long-term study called ‘The RISE Report on Cannabis and Sexual Health and Wellness’.

  • Newsfilelast month

    RISE Closes Deal to Buy Cultivate Kind and Life Bloom Organics

    Precedent-setting acquisition immediately expands the RISE product portfolio and deepens the company's vertical integration as it rolls out cannabis-based health and wellness products in the California market Toronto, Ontario--(Newsfile Corp. - July 12, 2018) - RISE Life Science Corp. (CSE: RLSC) (the "Company and/or "RISE") has completed the previously announced acquisition of 100% interest in California-based Cultivate Kind and Life Bloom Organics.The acquisition of Life Bloom Organics will immediately expand RISE's portfolio of CBD products ...

  • GlobeNewswirelast month

    Exclusive CFN Media Interview: RISE Life Science Study on Cannabis and Sexual Health (Part 1)

    CFN Media Group (“CFN Media”), the leading agency and financial media network dedicated to the North American cannabis industry, announces publication of an exclusive interview with Dr. Regina Nelson, who is leading a long-term study of sexual health and wellness and how it relates to cannabis for RISE Life Science Corp. (RLSC.CN) (RLSC.CN) (RLSC.CN). 1.   You are working with RISE Life Science to implement a broad and long-term study called ‘The RISE Report on Cannabis and Sexual Health and Wellness’. RISE Life Science is developing and commercializing cannabis-based products for sexual health and wellness.

  • Newsfilelast month

    RISE Life Science Corp. Announces Closing $1.4M of Equity Financing

    — Canadian Health and Wellness Product Pioneer Poised for Growth and Expansion — Toronto, Ontario--(Newsfile Corp. - July 3, 2018) - RISE Life Science Corp. (CSE: RLSC) (the "Company" or "RISE") today announces that it has closed a non-brokered private placement (the "Offering") through the issuance of an aggregate of 4,824,399 units (each a "Unit") at a price of $0.30 per Unit for gross proceeds of $1,447,319.70. Each Unit is comprised of one common ...

  • Newsfile2 months ago

    RISE Life Science Corp. Announces U.S. Retail Debut of Karezza, New CBD Brand

    Canadian Health and Wellness Product Pioneer brings first products to market Toronto, Ontario--(Newsfile Corp. - June 21, 2018) - RISE Life Science Corp. (CSE: RLSC) (the "Company" and/or "RISE") today announced the launch of its CBD-based wellness brand, Karezza, at retail in California as of June 20, 2018.Karezza is a suite of sexual wellness supplements that today includes a couples "In the Moment" mood support supplement, plus a "Women's Daily" supplement and a "Men's Daily" ...

  • Newsfile2 months ago

    RISE Life Science Provides Operational Update

    Toronto, Ontario--(Newsfile Corp. - June 8, 2018) - RISE Life Science Corp. (CSE: RLSC) (the "Company" and/or "RISE"), today provided an operational update on its plans and projected timelines for the 2018 calendar year. RISE is pleased to announce that it expects to launch its own commercial products for sale in the California market on or about its previously announced launch date of 6/20/2018."With the recent introduction of the RISE Report on SEX ...

  • Newsfile2 months ago

    RISE Life Science Corp. to Acquire California CDB Company Life Bloom Organics and Leading Cannabis Brand Strategy Agency Cultivate Kind

    Toronto, Ontario--(Newsfile Corp. - June 7, 2018) - RISE Life Science Corp. (CSE: RLSC) (the "Company" and/or "RISE")  is pleased to announce that it has signed a Letter of Intent (LOI) to acquire 100% of Life Bloom Organics, LLC, a California company that produces and markets organic oral sprays containing CBD, and 100% of Cultivate Kind, one of the top marketing and branding agencies for the cannabis industry in the United States."This represents a ...

  • GlobeNewswire3 months ago

    RISE Life Science: Commitment to the Highest Quality Cannabis Products for Sexual Health and Wellness -- CFN Media

    CFN Media Group (“CFN Media”), the leading agency and financial media network dedicated to the North American cannabis industry, announces publication of an article discussing RISE Life Science Corp. (CSE:RLSC), the importance of consistent high quality in the emerging cannabis market, and the company’s commitment to best practices, ingredients, and science. As the cannabis industry matures, both in North America and across the globe, regulations and consumer demands will require companies to produce consistent, high quality products that are safe and effective. Gone are the days of illicit weed grown with questionable practices, as the black market is being replaced by regulated operations offering a variety of cannabis products scientifically developed for use in distinct applications.

  • Newsfile4 months ago

    RISE Life Science Corp. Announces the RISE Report: A Study to Explore Cannabis Use and Sexual Health

    Study to reveal the health benefits of cannabis products and their relation to sexual health Toronto, Ontario--(Newsfile Corp. - April 24, 2018) - RISE Life Science Corp. (CSE: RLSC) (formerly Luminor Medical Technologies Inc.) (the "Company" and/or "RISE") today announced that it has commissioned a longitudinal study to investigate sexual function and health concerns, and, how cannabis products designed for sexual enhancement and health affect sexual behaviors and performance. The RISE Report on Cannabis ...

  • Newsfile4 months ago

    RISE Life Science Corp. Announces Closing $2.2M of Equity Financing

    Toronto, Ontario--(Newsfile Corp. - April 19, 2018) - RISE Life Science Corp. (CSE: RLSC) (formerly Luminor Medical Technologies Inc. (the "Company" or "RISE") is pleased to announce that, further to it press release dated March 29, 2018, it has closed tranches (each a "Tranche") of its previously announced non-brokered private placement (the "Offering") through the issuance of an aggregate of 7,366,166 units (each a "Unit") at a price of $0.30 per Unit for gross ...

  • Newsfile5 months ago

    RISE Life Science Announces Private Placement of Units

    Toronto, Ontario--(Newsfile Corp. - March 29, 2018) - RISE Life Science Corp. (CSE: RLSC) (formerly Luminor Medical Technologies Inc.) (the "Company") announces that it intends to complete a non-brokered private placement of up to 10,000,000 units ("Units") at a price of $0.30 per Unit (the "Issue Price") for gross proceeds of up to $3,000,000 (the "Offering"). Each Unit will be comprised of one common share ("Common Share") of the Company and one-half of ...